J&J Hit With $417M Verdict In 1st Calif. Talc Cancer Trial

Law360, Los Angeles (August 21, 2017, 1:24 PM EDT) -- The first California state jury to evaluate the possible link between Johnson & Johnson’s talcum powder products and ovarian cancer set a high-water mark on Monday with a $417 million verdict for the company’s role in causing a woman’s terminal cancer, surpassing large awards from earlier trials in Missouri.

The jury awarded plaintiff Eva Echeverria $70 million in compensatory damages and slapped J&J and its subsidiary and co-defendant Johnson & Johnson Consumer with $347 million in punitive damages. (AP) After two days of deliberations following the four-week trial in Los Angeles, the jury found for plaintiff Eva Echeverria, finding that J&J...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!